ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity.

Mario Luppi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.